Loading…
Creative Medical Technology Holdings, Inc. is projected to rise to $2.94 by 2027, a +27% move from its current price of $2.31. CELZ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.25 | $2.31 | $2.37 | +0.04% |
| May 30 | $2.23 | $2.31 | $2.40 | +0.09% |
| May 31 | $2.22 | $2.31 | $2.42 | +0.13% |
| Jun 1 | $2.20 | $2.31 | $2.43 | +0.17% |
| Jun 2 | $2.19 | $2.32 | $2.45 | +0.22% |
| Jun 3 | $2.18 | $2.32 | $2.46 | +0.26% |
| Jun 4 | $2.17 | $2.32 | $2.48 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.17 | $2.32 | $2.48 | +0.30% |
| Week 2 | $2.12 | $2.32 | $2.55 | +0.61% |
| Week 3 | $2.08 | $2.33 | $2.61 | +0.92% |
| Week 4 | $2.05 | $2.34 | $2.67 | +1.22% |
| Week 5 | $2.02 | $2.35 | $2.72 | +1.53% |
| Week 6 | $2.00 | $2.35 | $2.77 | +1.84% |
| Week 7 | $1.98 | $2.36 | $2.81 | +2.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company focused on novel biological therapeutics across immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.
It develops AlloStem (CELZ-201-DDT), ImmCelz (CELZ-100), CELZ-201 CREATE-1 (phase 2 for type 1 diabetes), AlloStemSpine (CELZ 201 ADAPT) in phase 2, and platforms including Alova, StemSpine, OvaStem, and CaverStem for erectile dysfunction and FemCelz for female sexual function, among other indications. Creative Medical Technology Holdings is based in Phoenix, Arizona.
Creative Medical Technology Holdings, Inc. trades under the ticker CELZ. The stock is currently priced at $2.39 per share with a market capitalization of $8.84M and a market rank of 5181. The near-term technical picture shows bullish momentum with a 30-day range of $2.01 to $2.84 and current price around the middle of recent activity.
A major floor 22.9% below — a decisive break under it would weaken the trend.
The nearest floor, 6.1% below — buyers have tended to step in here.
The nearest ceiling, 6.9% above — a clean break opens room to run.
A major ceiling 13.3% above — clearing it would confirm fresh momentum.
Key CELZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CELZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.32 | Sell | $2.31 | Sell |
| MA 10 | $2.27 | Buy | $2.29 | Buy |
| MA 20 | $2.26 | Buy | $2.26 | Buy |
| MA 50 | $2.16 | Buy | $2.19 | Buy |
| MA 100 | $2.07 | Buy | $2.22 | Buy |
| MA 200 | $2.57 | Sell | $2.41 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.88 | Neutral |
| Stoch RSI (14) | 49.38 | Neutral |
| CCI (20) | 81.45 | Neutral |
| Williams %R (14) | -38.10 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 61.90 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 57.51 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 2.37 | Sell |
| ADX (14) | 10.85 | Neutral |
| ATR (14) | 0.05 | Info |
The sentiment indicator is BULLISH with RSI14 at 60. The stock trades above the 30-day window and is sandwiched between the 50-day simple moving average of $2.15 and the 200-day simple moving average at $2.58. Near-term support is at $2.17 and resistance at $2.47, framing a 30-day trading range of $2.01 to $2.84.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.78 | $2.31 | $3.21 | 0% | Neutral | |
| $2.35 | $2.94 | $3.88 | +27% | Bullish | |
| $2.33 | $2.99 | $4.08 | +29% | Bullish | |
| $2.53 | $3.31 | $4.64 | +43% | Bullish | |
| $2.72 | $3.62 | $5.19 | +57% | Bullish | |
| $3.07 | $4.15 | $6.07 | +80% | Bullish | |
| $3.71 | $5.10 | $7.58 | +121% | Bullish | |
| $4.06 | $5.67 | $8.56 | +145% | Bullish | |
| $4.41 | $6.23 | $9.56 | +170% | Bullish | |
| $4.55 | $6.52 | $10.13 | +182% | Bullish | |
| $6.97 | $10.60 | $17.45 | +359% | Bullish | |
| $11.12 | $18.72 | $33.52 | +710% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.78 | $2.31 | $2.72 | +0.00% |
| June 2026 | $2.06 | $2.41 | $2.89 | +4.49% |
| July 2026 | $2.03 | $2.40 | $2.92 | -0.43% |
| August 2026 | $2.01 | $2.39 | $2.93 | -0.51% |
| September 2026 | $2.07 | $2.47 | $3.05 | +3.41% |
| October 2026 | $2.11 | $2.53 | $3.14 | +2.20% |
| November 2026 | $2.08 | $2.51 | $3.14 | -0.79% |
| December 2026 | $2.11 | $2.56 | $3.21 | +1.92% |
Click any year to see its month-by-month CELZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Creative Medical Technology Holdings, Inc.'s 2026 outlook centres on $2.31, within a $1.78 to $3.21 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CELZ could reach as high as $3.88, with a base case around $2.94 and support toward $2.35 — roughly +27% from $2.31. Momentum favours further upside here.
Expect CELZ to range from $2.33 to $4.08 through 2028. The $2.99 average target implies a +29% move from current prices. That is up +2% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CELZ price prediction for 2029 points to an average of $3.31 (low $2.53, high $4.64) — a potential gain of +43% on today's $2.31. Momentum favours further upside here.
In 2030, CELZ is projected to trade between $2.72 and $5.19, averaging $3.62 — a potential gain of +57% from today's $2.31. That is up +9% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Creative Medical Technology Holdings, Inc.'s 2031 outlook centres on $4.15, within a $3.07 to $6.07 range. That is up +15% on the projected 2030 average. That marks a +80% change versus current levels. Momentum favours further upside here.
By 2032, CELZ could reach as high as $7.58, with a base case around $5.10 and support toward $3.71 — roughly +121% from $2.31. Buyers look set to stay in control over this stretch.
Expect CELZ to range from $4.06 to $8.56 through 2033. The $5.67 average target implies a +145% move from current prices. That is up +11% on the projected 2032 average. Momentum favours further upside here.
The CELZ price prediction for 2034 points to an average of $6.23 (low $4.41, high $9.56) — a potential gain of +170% on today's $2.31. Buyers look set to stay in control over this stretch.
In 2035, CELZ is projected to trade between $4.55 and $10.13, averaging $6.52 — a potential gain of +182% from today's $2.31. That is up +5% on the projected 2034 average. Momentum favours further upside here.
Creative Medical Technology Holdings, Inc.'s 2040 outlook centres on $10.60, within a $6.97 to $17.45 range. That is up +63% on the projected 2035 average. That marks a +359% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CELZ could reach as high as $33.52, with a base case around $18.72 and support toward $11.12 — roughly +710% from $2.31. Momentum favours further upside here.
Investing $1,000 in CELZ today (≈ 432.900433 CELZ) could be worth
$8,102.44
+$7,102.44 (+710%) by 2050 · US Dollar
Based on the average projected CELZ price of $18.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CELZwould be worth at today's price.
$1,000 invested in CELZ on May 27, 2025 (≈ 487.804889 CELZ) would be worth
$1,126.83
+$126.83 (+12.7%) today · 1.13× · US Dollar
Based on a CELZ entry price of $2.05 vs. today's $2.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.27 | $1,017.62 | +1.8% |
| 1 month ago | $2.28 | $1,013.16 | +1.3% |
| 3 months ago | $1.84 | $1,255.43 | +25.5% |
| 6 months ago | $2.69 | $858.74 | -14.1% |
| 1 year ago | $2.05 | $1,126.83 | +12.7% |
| All time (5.0y) ago | $179.5 | $12.87 | -98.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CELZ forecast.
Our base-case forecast reaches $4.60 around 2032.
Implied market cap at $4.60: $17M
The multi-year forecast shows an upward path from 2026 onward. For 2026 the avg price is $2.39 with ROI 0 and sentiment Neutral. In 2027 the avg rises to $3.11 (ROI 30) with a bullish tone, followed by 2028 at $3.16 (ROI 32.4) and 2029 at $3.60 (ROI 50.5), both bullish.
By 2030 the avg is $3.97 (ROI 66) and sentiment remains bullish. The trajectory continues with 2031 at $4.60 (ROI 92.7), 2032 at $5.79 (ROI 142.1), 2033 at $6.41 (ROI 168.3), 2034 at $7.06 (ROI 195.6), and 2035 at $7.49 (ROI 213.2). Looking further ahead, 2040 shows an avg of $12.43 (ROI 419.9) and 2050 an avg of $22.53 (ROI 842.6), both with bullish sentiment.
These figures imply substantial long-term upside with corresponding upside potential and notable uncertainty as with any forecast.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg price of $3.97 per share, with a min of $2.96 and a max of $5.73; ROI is 66% and sentiment is BULLISH.
The 2026 forecast shows an avg of $2.39 with ROI of 0 and sentiment Neutral. Longer term, the forecast shows bullish upside with 2030 avg $3.97 (ROI 66%), 2040 avg $12.43 (ROI 419.9%), and 2050 avg $22.53 (ROI 842.6%). These are estimates and involve uncertainty.
Yes, the forecast includes higher-price possibilities: 2040 max is $20.72 and 2050 max is $40.97, with 2040 avg $12.43 and 2050 avg $22.53. A $10 target lies within the forecasted range, though it is not guaranteed.
The current price is $2.39 per share and the market capitalization is $8.84M.
The 30-day range is $2.01 to $2.84. The stock has a bullish sentiment, RSI14 is 60, SMA50 is $2.15, SMA200 is $2.58, with near-term support at $2.17 and resistance at $2.47.
Creative Medical Technology Holdings, Inc. Community Discussion
0Share your Creative Medical Technology Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.